Therapy in thoracic oncology

Oral Presentation
Chairs: J-P. Sculier (Brussels, Belgium), E. Quoix (Strasbourg, France)
Aerosoltherapy in lung cancer
L. Guilleminault, A. Maillet, S. Pesnel, G. Paintaud, N. Congy-Jolivet, G. Thibault, H. Watier, S. Lerondel, L. Etienne, N. Heuze-Vourc‘h (Tours, Orleans, France)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Bevacizumab as first line treatment for advanced non-small cell lung cancer (NSCLC): a meta-analysis of randomised placebo-controlled trials (RCTs)
M. Borges, J. Costa, S. Paulo, L. Pinheiro, A. Vaz-Carneiro (Lisboa, Portugal)
Congress or journal article abstractSlide presentationMultimedia files
Congress or journal article abstractSlide presentationMultimedia files
Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial
D. Stroyakovskiy, C. Zhou, Z. Guan, W. Spengler, M. Wang, Y. D. Ko, C. K. Cheng, J. Mezger, A. Bearz, N. Pavlakis (Moscow, Russian Federation; Shanghai, Guangzhou, Beijing, China; Gerlingen, Bonn, Karlsruhe, Germany; Kowloon, Hong Kong; Aviano (PN), Italy
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung cancer
M. Liu, C. He, J. Xu (Guangzhou, China)
Congress or journal article abstractSlide presentationE-posterMultimedia files
Congress or journal article abstractSlide presentationE-posterMultimedia files
Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer
C. He, M. Liu, J. Xu (Guangzhou, China)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation (CRT) in patients with unresectable stage III non-small-cell-lung cancer (NSCLC): Cher@Nos trial
P. Germonpré, A. Janssens, L. Van Moorter, D. Verresen, D. Galdermans, R. Devogelaere, H. Ottevaere, Y. Menstens, C. De Pooter, C. Goor (Antwerp, Aalst, Wilrijk, Oostende, Oudenaarde, Herentals, Belgium)
Congress or journal article abstract
Congress or journal article abstract
Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung cancer – a pilot study
A. Gröschel, U. Nestle, J. Fleckenstein, Y. Ploner, A. Schaefer-Schuler, S. Kremp, D. Hellwig, C. Rübe, C. M. Kirsch, G. W. Sybrecht (Homburg/Saar, Germany)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Radiofrequency ablation of primary lung tumours (4 years experience in the university hospital of Coimbra, Portugal)
A. Szantho, A. Pego, G. Teixeira, F. Alves, A. Marques, M. Loureiro, M. F. Baganha (Coimbra, Portugal)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster